2,4-Diamino-6-[N-(2,3,5-trichlorobenzyl)-N-ethylamino]quinazoline

ID: ALA522543

PubChem CID: 25132197

Max Phase: Preclinical

Molecular Formula: C17H16Cl3N5

Molecular Weight: 396.71

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCN(Cc1cc(Cl)cc(Cl)c1Cl)c1ccc2nc(N)nc(N)c2c1

Standard InChI:  InChI=1S/C17H16Cl3N5/c1-2-25(8-9-5-10(18)6-13(19)15(9)20)11-3-4-14-12(7-11)16(21)24-17(22)23-14/h3-7H,2,8H2,1H3,(H4,21,22,23,24)

Standard InChI Key:  LAQLUYMJSYVNIA-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
   -4.0889  -25.0041    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0901  -25.8315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3753  -26.2444    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3771  -24.5914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6617  -25.0005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6609  -25.8273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9456  -26.2383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2306  -25.8235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2354  -24.9936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9513  -24.5863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3795  -23.7664    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8049  -26.2434    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5234  -24.5767    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1935  -24.9849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9055  -24.5680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6202  -24.9796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3317  -24.5634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3271  -23.7376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6051  -23.3296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8966  -23.7481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5284  -23.7517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2454  -23.3436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6230  -25.8046    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.0484  -24.9719    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.5972  -22.5047    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2 12  1  0
  5  6  1  0
  9 13  1  0
  3  6  2  0
 13 14  1  0
  6  7  1  0
 14 15  1  0
  1  2  2  0
 15 16  2  0
  7  8  2  0
 16 17  1  0
  5  4  2  0
 17 18  2  0
  8  9  1  0
 18 19  1  0
  4  1  1  0
 19 20  2  0
 20 15  1  0
  9 10  2  0
 13 21  1  0
 10  5  1  0
 21 22  1  0
 16 23  1  0
  4 11  1  0
 17 24  1  0
  2  3  1  0
 19 25  1  0
M  END

Associated Targets(non-human)

Dihydrofolate reductase (1239 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dhfr Dihydrofolate reductase (2343 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dihydrofolate reductase (1637 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
folA Dihydrofolate reductase (350 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 396.71Molecular Weight (Monoisotopic): 395.0471AlogP: 4.78#Rotatable Bonds: 4
Polar Surface Area: 81.06Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.40CX LogP: 5.04CX LogD: 4.75
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.62Np Likeness Score: -1.37

References

1. Gangjee A, Adair OO, Pagley M, Queener SF..  (2008)  N9-substituted 2,4-diaminoquinazolines: synthesis and biological evaluation of lipophilic inhibitors of pneumocystis carinii and toxoplasma gondii dihydrofolate reductase.,  51  (19): [PMID:18771252] [10.1021/jm800694g]

Source